Zhejiang Hisoar Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002099.SZ

Zhejiang Hisoar Pharmaceutical Co., Ltd. EBITDA Margin for the year ending December 31, 2023: -2.03%

Zhejiang Hisoar Pharmaceutical Co., Ltd. EBITDA Margin is -2.03% for the year ending December 31, 2023, a -110.77% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Zhejiang Hisoar Pharmaceutical Co., Ltd. EBITDA Margin for the year ending December 31, 2022 was 18.81%, a 4.35% change year over year.
Zhejiang Hisoar Pharmaceutical Co., Ltd. EBITDA Margin for the year ending December 31, 2021 was 18.02%, a -34.74% change year over year.
Zhejiang Hisoar Pharmaceutical Co., Ltd. EBITDA Margin for the year ending December 31, 2020 was 27.62%, a -24.35% change year over year.
Zhejiang Hisoar Pharmaceutical Co., Ltd. EBITDA Margin for the year ending December 31, 2019 was 36.51%, a 5.67% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Shenzhen Stock Exchange: 002099.SZ

Zhejiang Hisoar Pharmaceutical Co., Ltd.

CEO	Mr. Guorui Xu
IPO Date	Dec. 26, 2006
Location	China
Headquarters	No. 100, Waisha Branch Road
Employees	2,612
Sector	Healthcare
Industries Pharmaceuticals Chemicals & Advanced Materials Cleaning Supplies Drugstores & Retail Pharmacies Personal Care Petrochemicals Plastics Tobacco

Description

Zhejiang Hisoar Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells fine chemicals and special raw drugs in China and internationally. It offers antibiotic, anti-virus, cardiovascular, sugar-reducing, and other materials; and medicine intermediates, and other customized and processed products, such as clindamycin, 4-AA Iso-carbapenem series, thiamphenicol, florfenicol, voglibose, eclindamycin, 4-AA iso-carbapenem, thiamphenicol, florfenicol, voglibose, etc. It also exports its products. The company was founded in 1966 and is based in Taizhou, China.

Key trends

Past 5 years